Word

NAVICAN

Status

Dead

Status Code

710

Status Date

Friday, March 29, 2024

Serial Number

87975639

Registration Number

5292993

Registration Date

Tuesday, September 19, 2017

Mark Type

4000

Filing Date

Thursday, June 30, 2016

Published for Opposition

Tuesday, November 8, 2016

Cancellation Date

Friday, March 29, 2024

Trademark Owner History

Intermountain Insights, LLC - Original Registrant

Classifications

36 Pharmaceutical benefit management services; insurance claims processing in the field of diagnostics and pharmaceutical claims; providing a database featuring information and statistics about patient reimbursement and insurance coverage for diagnostics and pharmaceuticals; and reimbursement payment processing in the field of diagnostics and pharmaceutical claims; and providing information in the field of financial support options and resources for prescribers, patients and the pharmaceutical industry; providing patient reimbursement and insurance coverage information in the field of drug reimbursement for prescribers, patients and the pharmaceutical industry; providing patient reimbursement and insurance coverage information in the field of diagnostics reimbursement for providers and patients; financial administration of diagnostics and pharmacy reimbursement programs and services

35 Pharmaceutical procurement services, namely, purchasing pharmaceuticals for others; pharmaceutical cost management services and drug utilization review services; assisting patients in enrolling in diagnostics and pharmaceutical reimbursement programs of others; providing business, pricing, reimbursement benchmarking and other market intelligence information in the field of drug reimbursement for prescribers, patients and the pharmaceutical industry; providing business, pricing, reimbursement benchmarking and other market intelligence information in the field of diagnostics reimbursement for providers and patients; business administration of diagnostics and pharmacy reimbursement programs and services; business management and consultation services in the field of specialty pharmacy, namely, assisting patients and providers with pharmaceutical reimbursement; business management and consultation services in the field of off label pharmaceuticals, namely, assisting patients and providers with pharmaceutical reimbursement; business management services in the field of diagnostics, namely, assisting patients and providers with diagnostics reimbursement; and promoting collaboration within the scientific, research and medical communities to achieve advances in the fields of healthcare and pharmaceuticals; business management of comprehensive programs involving drug therapy

44 Dispensing of pharmaceuticals; medical and pharmaceutical consultation; pharmaceutical advice; pharmaceutical compounding services; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; medical services, namely, providing personalized drug therapy management programs to cancer patients based on the patient's genetic testing results; genetic testing for medical purposes; genetic testing for cancer diagnosis, treatment and prevention purposes; providing genetic sequencing and consulting services via website designed to provide cancer patients and oncologists with custom tailored information about the range of possible treatments and drug therapies for a particular cancer; providing information to patients and physicians via a website to recommend cancer treatment and drug therapies based on the patient's genetic testing results; providing personalized drug therapy services for cancer patients; drug utilization review dispensing services via a website, namely, identifying cancer drug therapies based on a patient's genetic testing results prior to dispensing medications; developing and managing comprehensive treatment programs involving drug therapy; physician support services in the nature of providing consultation in the dispensing of prescription drugs for persons with particular cancers; providing medical evaluations of patients to determine acceptability for participation in clinical trials; providing healthcare counseling, screening, diagnosis, prognosis, treatment, relapse, palliative, integrative medicine, survivorship, and other related medical information in the field of oncology; providing a database in the field of oncology and featuring inputting and collection of data and information all for treatment and diagnosis purposes; healthcare consultation in the field of cancer treatment research, namely, advising patients on cancer treatment research studies in which they might participate for purposes of treating their conditions; providing an online searchable database in the fields of oncolology, bioinformatics, clinical information technology, genomic data and genomic sequence analysis for personalized diagnosis, treatment and prevention of cancer

42 Medical, clinical and scientific research in the field of oncology, namely, research relating to genetic diagnostic assays and pharmaceuticals for personalized diagnosis, treatment and prevention of cancer; scientific and technological services, namely, research services for medical purposes in the field of genetic diagnostic assays and pharmaceuticals research for personalized diagnosis, treatment and prevention of cancer; providing medical and scientific research information and scientific consulting in the field of genetic diagnostic assays and pharmaceuticals for diagnosis, treatment and prevention of cancer; conducting early evaluations in the field of new genetic diagnostics assays and pharmaceuticals; development, evaluation and medical and scientific research of genetic diagnostic assays for personalized diagnosis, treatment and prevention of cancer; laboratory research services relating to genetic diagnostic assays for personalized diagnosis, treatment and prevention of cancer; providing medical and scientific research information in the field of genetic diagnostic assays, pharmaceuticals, clinical trials and genetics; technical consulting related to scientific and medical studies in the field of genetic diagnostic assay and pharmaceuticals for personalized diagnosis, treatment and prevention of cancer; basic and clinical research in the field of oncology, namely, researching genetic diagnostic assays and pharmaceuticals for personalized diagnosis, treatment and prevention of cancer; providing medical and scientific research information in the field of genetic diagnostic assays, pharmaceuticals and clinical trials for personalized diagnosis, treatment and prevention of cancer; custom design and development of chemical reagants and multiplex sequencing assays for personalized diagnosis, treatment and prevention of cancer; providing an on-line computer database featuring medical and scientific research information in the field of oncology that allows for input and collection of scientific and research data and information relating to genetic diagnostic assays and pharmaceuticals for diagnosis, treatment and prevention of cancer; data collection for research purposes, namely, data mining and pattern recognition, designing clinical studies, and generating genomic data from patient samples for personalized diagnosis, treatment and prevention of cancer; data collection for research purposes, namely, the collection and systematic sorting of clinical and patient data comprising patient specific clinical data and scientific clinical studies relating to genetic diagnostic assays and pharmaceuticals for personalized diagnosis, treatment and prevention of cancer; data collection for research purposes, namely, the collection of mathematical and statistical data, clinical data, patient data and data of clinical studies relating to clinical response to cancer treatments for personalized diagnosis, treatment and prevention of cancer; compiling data for research purposes in the field of medical science, namely, compiling patient specific molecular and genomic data, patient specific clinical data and scientific clinical studies for personalized diagnosis, treatment and prevention of cancer; providing a website featuring technology with a web-based interface where medical professionals can view genetic test results and interpretations of the results by scientists and medical professionals in the field of genomics, and select the appropriate treatment and order the necessary pharmaceutical products

Trademark Events

Mar 29, 2024

Cancelled Sec. 8 (6-Yr)

Sep 19, 2022

Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed

Sep 19, 2017

Registered-Principal Register

Aug 18, 2017

Notice Of Acceptance Of Statement Of Use E-Mailed

Aug 17, 2017

Allowed Principal Register - Sou Accepted

Aug 1, 2017

Statement Of Use Processing Complete

Jun 30, 2017

Use Amendment Filed

Aug 1, 2017

Divisional Processing Complete

Jun 30, 2017

Divisional Request Received

Jul 21, 2017

Case Assigned To Intent To Use Paralegal

Jun 30, 2017

Teas Request To Divide Received

Jun 30, 2017

Teas Statement Of Use Received

Jan 3, 2017

Noa E-Mailed - Sou Required From Applicant

Nov 8, 2016

Official Gazette Publication Confirmation E-Mailed

Nov 8, 2016

Published For Opposition

Oct 19, 2016

Notification Of Notice Of Publication E-Mailed

Oct 4, 2016

Law Office Publication Review Completed

Sep 27, 2016

Assigned To Lie

Sep 14, 2016

Approved For Pub - Principal Register

Sep 14, 2016

Examiner's Amendment Entered

Sep 14, 2016

Notification Of Examiners Amendment E-Mailed

Sep 14, 2016

Examiners Amendment E-Mailed

Sep 14, 2016

Examiners Amendment -Written

Sep 7, 2016

Assigned To Examiner

Jul 14, 2016

Teas Amendment Entered Before Attorney Assigned

Jul 14, 2016

Teas Voluntary Amendment Received

Jul 6, 2016

New Application Office Supplied Data Entered

Jul 4, 2016

New Application Entered